Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.Financial_Report.xls
10-Q - QUARTERLY REPORT - ASSEMBLY BIOSCIENCES, INC.v326006_10q.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R6.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R4.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R8.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R7.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R1.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R2.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R9.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R18.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R17.htm
EX-31.1 - CERTIFICATION - ASSEMBLY BIOSCIENCES, INC.v326006_ex31-1.htm
EX-32.1 - CERTIFICATION - ASSEMBLY BIOSCIENCES, INC.v326006_ex32-1.htm
EX-31.2 - CERTIFICATION - ASSEMBLY BIOSCIENCES, INC.v326006_ex31-2.htm
EX-32.2 - CERTIFICATION - ASSEMBLY BIOSCIENCES, INC.v326006_ex32-2.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R5.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R13.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R19.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R11.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R15.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R14.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R12.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R20.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R23.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R16.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R21.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R3.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R10.htm
v2.4.0.6
Estimated Future Stock-Based Compensation Expense Relating to Unvested Stock Options (Detail) (USD $)
Sep. 30, 2012
Stockholders Equity Note [Line Items]  
2012 (October through December) $ 693,373
2013 1,382,334
2014 566,351
2015 9,914
Total estimated future stock-based compensation expense - stock options $ 2,651,972